ClinicalTrials.govpublic full text
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, nafld, fatty liver disease, nash, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 848531
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.